Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-12
2011-07-12
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S029000, C549S041000
Reexamination Certificate
active
07977374
ABSTRACT:
The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt or stereoisomer thereof. The compounds of the present invention are inhibitors of histone deacetylase (HDAC) and are useful for treating cellular proliferative diseases, including cancer. Further, the compounds of the present invention are useful for treating neurodegenerative diseases, schizophrenia and stroke among other diseases.
REFERENCES:
patent: 6492388 (2002-12-01), Harling et al.
patent: 7799825 (2010-09-01), Ferrigno et al.
patent: 2003/0013757 (2003-01-01), Leser-Reiff et al.
patent: 2004/0122079 (2004-06-01), Grossmann et al.
patent: 2004/0157841 (2004-08-01), Fertig et al.
patent: 2004/0162317 (2004-08-01), Fertig et al.
patent: WO 02/46129 (2002-06-01), None
patent: WO 02/069947 (2002-09-01), None
patent: WO 02/090534 (2002-11-01), None
patent: WO 03/099760 (2003-12-01), None
patent: WO 2004/054999 (2004-07-01), None
patent: WO 2004/069803 (2004-08-01), None
patent: WO 2005/121119 (2005-12-01), None
patent: WO 2005/121120 (2005-12-01), None
patent: WO 2005/121134 (2005-12-01), None
patent: WO 2006/005941 (2006-01-01), None
patent: WO 2006/005955 (2006-01-01), None
patent: WO 2006/061638 (2006-06-01), None
Graham, et al., “Preparation and Utility of Dianions from N-tert-Butylthiophene-2-sulfonamide”, J. Org. Chem., vol. 56, pp. 4260-4263 (1991).
Doucet-Personeni, et al., “A Structure-Based Design Approach to the Development of Novel, Reversible AChE Inhibitors”, J. Med. Chem., vol. 44, pp. 3203-3215 (2001).
Frey, et al., “Trifluoromethyl Ketones as Inhibitors of Histone Deacetylase”, Bioorganic & Medicinal Chemistry Letters, vol. 12, pp. 3443-3447 (2002).
Notice of Allowance mailed Aug. 26, 2010 in U.S. Appl. No. 11/792,294.
Ferrigno Federica
Jones Philip
Muraglia Ester
Ontoria Ontoria Jesus Maria
Scarpelli Rita
Istituto di Ricerche di Biologia Molecolare P. Angeletti SpA
Javanmard Sahar
Muthard David A.
Padmanabhan Sreeni
Su Li
LandOfFree
Thiophene and thiazole substituted trifluoroethanone... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiophene and thiazole substituted trifluoroethanone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiophene and thiazole substituted trifluoroethanone... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2670436